GT
Glenmede Trust Portfolio holdings
AUM
$18.6B
1-Year Est. Return
8.78%
1 Year Est. Return
+8.78%
AUM
$19.6B
AUM Growth
-$1.32B
(-6.3%)
Holding
1,468
Top Buys
| 1 | +$96.4M | |
| 2 | +$63.8M | |
| 3 | +$46.6M | |
| 4 |
Lam Research
LRCX
|
+$37M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$22M |
Top Sells
| 1 | +$119M | |
| 2 | +$74.9M | |
| 3 | +$64.6M | |
| 4 |
Merck
MRK
|
+$59.5M |
| 5 |
Home Depot
HD
|
+$40.2M |
Sector Composition
| 1 | Technology | 23.77% |
| 2 | Financials | 10.7% |
| 3 | Healthcare | 9.86% |
| 4 | Consumer Discretionary | 9.05% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Intel
INTC
$198B
| $30.3M | 0.15% |
1,512,410
+343,723
|
|
||
127
Intercontinental Exchange
ICE
$90B
| $30M | 0.15% |
201,453
+1,792
|
|
||
128
Eaton
ETN
$131B
| $29.9M | 0.15% |
90,077
+3,506
|
|
||
129
Air Products & Chemicals
APD
$58B
| $29.6M | 0.15% |
102,071
-10,208
|
|
||
130
TE Connectivity
TEL
$68.9B
| $29.2M | 0.15% |
203,894
+9,630
|
|
||
131
Intuitive Surgical
ISRG
$204B
| $28.6M | 0.15% |
54,735
+1,170
|
|
||
132
United Parcel Service
UPS
$80.5B
| $28.5M | 0.15% |
226,037
-118,572
|
|
||
133
IBM
IBM
$288B
| $27.8M | 0.14% |
126,609
-43,668
|
|
||
134
US Bancorp
USB
$79.7B
| $27.7M | 0.14% |
578,493
-66,815
|
|
||
135
Bank of New York Mellon
BK
$79.5B
| $27.7M | 0.14% |
360,058
-38,874
|
|
||
136
Becton Dickinson
BDX
$55.4B
| $26.8M | 0.14% |
118,027
-1,784
|
|
||
137
Zoetis
ZTS
$52.3B
| $26.4M | 0.13% |
162,085
+13,798
|
|
||
|
138
Regeneron Pharmaceuticals
REGN
$75.5B
| $26.4M | 0.13% |
37,010
+30,915
|
|
||
139
Philip Morris
PM
$230B
| $26.3M | 0.13% |
218,798
-20,661
|
|
||
140
Hewlett Packard
HPE
$30.8B
| $26.3M | 0.13% |
1,232,940
-164,569
|
|
||
141
Axalta
AXTA
$6.2B
| $26.3M | 0.13% |
768,074
+13,535
|
|
||
142
Western Alliance Bancorporation
WAL
$9.39B
| $25.8M | 0.13% |
309,343
-2,643
|
|
||
143
Edwards Lifesciences
EW
$50B
| $25.8M | 0.13% |
349,050
-32,118
|
|
||
144
Expedia Group
EXPE
$32.3B
| $25.7M | 0.13% |
137,699
+3,293
|
|
||
145
Novo Nordisk
NVO
$213B
| $25.6M | 0.13% |
297,592
+2,162
|
|
||
146
Stryker
SYK
$139B
| $24.9M | 0.13% |
69,030
+880
|
|
||
147
Oneok
OKE
$48B
| $24.8M | 0.13% |
246,865
-55,080
|
|
||
148
Baker Hughes
BKR
$48.5B
| $24.8M | 0.13% |
604,191
-49,854
|
|
||
149
Target
TGT
$41.7B
| $24.6M | 0.13% |
181,897
-7,627
|
|
||
150
Gilead Sciences
GILD
$150B
| $24.3M | 0.12% |
263,376
-28,672
|
|